NO20074616L - Antistoffer mot Candida antigener - Google Patents
Antistoffer mot Candida antigenerInfo
- Publication number
- NO20074616L NO20074616L NO20074616A NO20074616A NO20074616L NO 20074616 L NO20074616 L NO 20074616L NO 20074616 A NO20074616 A NO 20074616A NO 20074616 A NO20074616 A NO 20074616A NO 20074616 L NO20074616 L NO 20074616L
- Authority
- NO
- Norway
- Prior art keywords
- antibodies
- candida antigens
- domain antibodies
- candida
- antigens
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0505489A GB0505489D0 (en) | 2005-03-18 | 2005-03-18 | Antibodies |
GBGB0519883.3A GB0519883D0 (en) | 2005-09-29 | 2005-09-29 | Antibodies |
PCT/GB2006/000843 WO2006097689A2 (en) | 2005-03-18 | 2006-03-10 | Antibodies against candida antigens |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20074616L true NO20074616L (no) | 2007-11-27 |
Family
ID=36808786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20074616A NO20074616L (no) | 2005-03-18 | 2007-09-12 | Antistoffer mot Candida antigener |
Country Status (12)
Country | Link |
---|---|
US (1) | US8092800B2 (es) |
EP (1) | EP1863845A2 (es) |
JP (1) | JP2008533115A (es) |
KR (1) | KR20080003351A (es) |
AU (1) | AU2006224438A1 (es) |
CA (1) | CA2601115A1 (es) |
EA (1) | EA200701766A1 (es) |
IL (1) | IL185781A0 (es) |
MA (1) | MA29394B1 (es) |
MX (1) | MX2007011356A (es) |
NO (1) | NO20074616L (es) |
WO (1) | WO2006097689A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006224438A1 (en) | 2005-03-18 | 2006-09-21 | Antonio Cassone | Antibodies against Candida antigens |
GB0624500D0 (en) * | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
US20090081196A1 (en) * | 2007-02-16 | 2009-03-26 | Istituto Superiore Di Sanita | Medicaments for fungal infections |
AU2009306424A1 (en) * | 2008-10-21 | 2010-04-29 | Domantis Limited | Ligands that have binding specificity for DC-SIGN |
US20110189183A1 (en) | 2009-09-18 | 2011-08-04 | Robert Anthony Williamson | Antibodies against candida, collections thereof and methods of use |
JP2014515757A (ja) * | 2011-04-21 | 2014-07-03 | ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティ アンド アグリカルチュラル アンド メカニカル カレッジ | 真菌感染症のペプチド及び結合型ワクチン |
CN107663239A (zh) * | 2016-12-28 | 2018-02-06 | 天津天锐生物科技有限公司 | 一种识别hla‑a2/nlvpmvatv的单域抗体 |
CN109336976B (zh) * | 2018-09-27 | 2021-04-02 | 暨南大学 | 抗人egfr的纳米抗体及其应用 |
WO2020130838A2 (en) * | 2018-12-21 | 2020-06-25 | Qvq Holding B.V. | Antibodies for preventing or treating candidiasis |
CN112646035B (zh) * | 2020-12-25 | 2022-06-24 | 暨南大学 | Egfr的亲和力成熟结合蛋白及应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE291586T1 (de) | 1999-02-01 | 2005-04-15 | Schering Ag | Humanes antibiotisches protein |
US7521053B2 (en) * | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US20030202975A1 (en) | 2002-02-21 | 2003-10-30 | Tedder Thomas F. | Reagents and treatment methods for autoimmune diseases |
ATE328906T1 (de) * | 2002-06-28 | 2006-06-15 | Domantis Ltd | Dual-specifische liganden mit erhöhter halbwertszeit |
JP2006520584A (ja) * | 2002-11-08 | 2006-09-14 | アブリンクス エン.ヴェー. | 安定化単一ドメイン抗体 |
JP2006517789A (ja) * | 2003-01-10 | 2006-08-03 | アブリンクス エン.ヴェー. | 治療用ポリペプチド、その相同物、その断片、および血小板媒介凝集の調節での使用 |
CA2518980A1 (en) * | 2003-03-14 | 2004-09-30 | Pharmacia Corporation | Antibodies to igf-i receptor for the treatment of cancers |
AU2004220325B2 (en) | 2003-06-30 | 2011-05-12 | Domantis Limited | Polypeptides |
DE05733048T1 (de) | 2004-04-06 | 2007-05-10 | Affibody Ab | Serumalbuminbindende peptidkonjugate zur arzneimittelherstellung |
US7563443B2 (en) * | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
AU2006224438A1 (en) | 2005-03-18 | 2006-09-21 | Antonio Cassone | Antibodies against Candida antigens |
GB0624500D0 (en) | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
-
2006
- 2006-03-10 AU AU2006224438A patent/AU2006224438A1/en not_active Abandoned
- 2006-03-10 EA EA200701766A patent/EA200701766A1/ru unknown
- 2006-03-10 WO PCT/GB2006/000843 patent/WO2006097689A2/en active Application Filing
- 2006-03-10 KR KR1020077023962A patent/KR20080003351A/ko not_active Application Discontinuation
- 2006-03-10 EP EP06710056A patent/EP1863845A2/en not_active Withdrawn
- 2006-03-10 CA CA002601115A patent/CA2601115A1/en not_active Abandoned
- 2006-03-10 MX MX2007011356A patent/MX2007011356A/es not_active Application Discontinuation
- 2006-03-10 JP JP2008501395A patent/JP2008533115A/ja active Pending
- 2006-03-10 US US11/886,492 patent/US8092800B2/en not_active Expired - Fee Related
-
2007
- 2007-09-06 IL IL185781A patent/IL185781A0/en unknown
- 2007-09-12 NO NO20074616A patent/NO20074616L/no not_active Application Discontinuation
- 2007-10-12 MA MA30301A patent/MA29394B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EP1863845A2 (en) | 2007-12-12 |
MA29394B1 (fr) | 2008-04-01 |
JP2008533115A (ja) | 2008-08-21 |
KR20080003351A (ko) | 2008-01-07 |
WO2006097689A3 (en) | 2007-03-15 |
MX2007011356A (es) | 2008-03-10 |
CA2601115A1 (en) | 2006-09-21 |
IL185781A0 (en) | 2008-01-06 |
EA200701766A1 (ru) | 2008-04-28 |
AU2006224438A1 (en) | 2006-09-21 |
US8092800B2 (en) | 2012-01-10 |
WO2006097689A2 (en) | 2006-09-21 |
US20080193450A1 (en) | 2008-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074616L (no) | Antistoffer mot Candida antigener | |
MA30497B1 (fr) | Anticorps et immunco-conjugues, et leurs utilisations. | |
MA30910B1 (fr) | Anticorps et immunoconjugues, et leurs utilisations | |
ECSP099027A (es) | Anticuerpos anti-dll4 y métodos que los usan | |
MA30945B1 (fr) | Anticorps anti-tat226 et immunoconjugués | |
UA92505C2 (ru) | Композиции на основе антитела против cd3 | |
TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
NO20083895L (no) | Anti-IGF-1R human monoklonalantibody formulering | |
CR20150088A (es) | Anticuerpos anti-notch1 nrr | |
EA201000777A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
TW200726479A (en) | Method of inducing neutralizing antibodies to human immunodeficiency virus | |
NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
PA8794201A1 (es) | Anticuerpos anti-cxcr5 humanizados, derivados de los mismos y su uso | |
CY1112277T1 (el) | ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ | |
MA33551B1 (fr) | Anticorps anti-egfl1 humanises, et procedes d'utilisation correspondants | |
MA30922B1 (fr) | Anticorps d'agonistes de trkb et leurs utilisations | |
PH12013502194A1 (en) | Antibodies to egfl7 and methods for their use | |
HN2006029142A (es) | Proceso | |
NO20083593L (no) | Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse | |
FR2897063B1 (fr) | Polypeptides reconnus par des anticorps anti-trichinella, et leurs applications. | |
WO2010053573A3 (en) | Screen for inhibitors of filovirus and uses therefor | |
CL2007002370A1 (es) | Conjugado que consta de un anticuerpo anti-ccr5 y uno o mas peptidos antifusogenicos; composicion farmaceutica que lo comprende; metodo de preparacion; y su uso para tratar infecciones virales. | |
WO2008105961A3 (en) | Reducing contrast agent-induced toxicity | |
MX2010000080A (es) | Dispositivo para gafas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |